Fennec Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Sep '25 Sep 4, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Market Capitalization	249	174	303	252	114	192	Upgrade
Market Cap Growth	37.31%	-42.68%	20.14%	120.31%	-40.49%	48.91%	Upgrade
Enterprise Value	249	165	316	247	95	159	Upgrade
Last Close Price	8.86	6.32	11.22	9.60	4.40	7.45	Upgrade
Forward PE	22.62	-	90.85	-	-	8.87	Upgrade
PS Ratio	7.31	3.65	14.25	164.24	-	1131.07	Upgrade
PB Ratio	-	-29.57	-26.06	-98.13	7.26	6.61	Upgrade
P/TBV Ratio	-	-	-	-	7.26	6.61	Upgrade
P/OCF Ratio	-	6.44	-	-	-	-	Upgrade
EV/Sales Ratio	7.48	3.48	14.88	160.94	-	935.98	Upgrade
EV/EBITDA Ratio	-	45.94	-	-	-	-	Upgrade
EV/EBIT Ratio	-	64.41	-	-	-	-	Upgrade
Debt / Equity Ratio	-2.59	-3.29	-2.66	-9.69	0.32	-	Upgrade
Debt / EBITDA Ratio	-	5.37	-	-	-	-	Upgrade
Asset Turnover	0.62	1.32	0.79	0.06	-	0.01	Upgrade
Inventory Turnover	1.55	1.98	0.92	-	-	-	Upgrade
Quick Ratio	4.30	5.71	2.92	5.49	12.76	12.93	Upgrade
Current Ratio	4.85	6.38	3.56	5.80	13.54	13.39	Upgrade
Return on Equity (ROE)	-	-	-	-359.22%	-77.36%	-88.45%	Upgrade
Return on Assets (ROA)	-11.20%	4.47%	-29.67%	-57.21%	-39.99%	-49.07%	Upgrade
Return on Capital (ROIC)	-28.57%	9.79%	-38.32%	-65.53%	-43.20%	-54.60%	Upgrade
Return on Capital Employed (ROCE)	-	6.80%	-	-	-	-	Upgrade
Earnings Yield	-4.85%	-0.25%	-5.30%	-9.41%	-15.16%	-9.42%	Upgrade
Buyback Yield / Dilution	3.63%	-2.71%	-1.14%	-1.03%	-9.71%	-19.14%	Upgrade

Updated Aug 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q